mifepristone has been researched along with 6-ketoprostaglandin f1 alpha in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peplow, PV | 2 |
| Descomps, B; Lobaccaro-Henri, C; Thaler-Dao, H | 1 |
| Adamson, L; Bocking, AD; Challis, JR; Fraser, M; Lye, SJ; McKeown, KJ; Riggs, KW; Rurak, D; Small, C | 1 |
4 other study(ies) available for mifepristone and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Prostaglandin E production by uteri of ovariectomized pregnant rats receiving antiprogesterone steroid or in which progesterone has been withdrawn.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Female; Gonanes; In Vitro Techniques; Mifepristone; Ovariectomy; Pregnancy; Progesterone; Prostaglandins E; Rats; Uterus | 1992 |
Uterine production of prostaglandins F2 alpha and 6-keto-F1 alpha by ovariectomized pregnant rats receiving antiprogesterone steroid or in which progesterone has been withdrawn.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Drug Implants; Epoprostenol; Estradiol; Female; Gonanes; Mifepristone; Organ Size; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains; Uterus | 1991 |
RU 38486 inhibits intracellular calcium mobilization and PGI2 release from human myometrium: mechanisms of action.
Topics: 6-Ketoprostaglandin F1 alpha; Abortifacient Agents, Steroidal; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Drug Synergism; Endoplasmic Reticulum; Enzyme Inhibitors; Epoprostenol; Female; Gallic Acid; Hormone Antagonists; Humans; Intracellular Fluid; Mifepristone; Muscle Relaxation; Myometrium; Nifedipine; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Staurosporine; Structure-Activity Relationship; Thapsigargin; Uterine Contraction | 1996 |
Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenocorticotropic Hormone; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Hydrocortisone; In Vitro Techniques; Isoenzymes; Labor, Induced; Meloxicam; Mifepristone; Pituitary-Adrenal System; Pregnancy; Prostaglandin-Endoperoxide Synthases; Sheep; Thiazines; Thiazoles; Tocolytic Agents; Uterine Contraction | 2000 |